Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Prevalence and Determinants of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients Screened Positive for Dementia: Results from the Population-Based DelpHi-Study.

Thyrian JR, Hertel J, Schulze LN, Dörr M, Prüss H, Hempel P, Bimmler M, Kunze R, Grabe HJ, Teipel S, Hoffmann W.

J Alzheimers Dis. 2018;64(4):1091-1097. doi: 10.3233/JAD-171096.

PMID:
30010118
2.

Capital jurors, mental illness, and the unreliability principle: Can capital jurors comprehend and account for evidence of mental illness?

Sandys M, Pruss H, Walsh SM.

Behav Sci Law. 2018 Jul 13. doi: 10.1002/bsl.2355. [Epub ahead of print]

PMID:
30004140
3.

Beyond the limbic system: disruption and functional compensation of large-scale brain networks in patients with anti-LGI1 encephalitis.

Heine J, Prüss H, Kopp UA, Wegner F, Then Bergh F, Münte T, Wandinger KP, Paul F, Bartsch T, Finke C.

J Neurol Neurosurg Psychiatry. 2018 Jun 9. pii: jnnp-2017-317780. doi: 10.1136/jnnp-2017-317780. [Epub ahead of print]

PMID:
29886429
4.

Encephalitis with mGluR5 antibodies: Symptoms and antibody effects.

Spatola M, Sabater L, Planagumà J, Martínez-Hernandez E, Armangué T, Prüss H, Iizuka T, Caparó Oblitas RL, Antoine JC, Li R, Heaney N, Tubridy N, Munteis Olivas E, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2018 May 29;90(22):e1964-e1972. doi: 10.1212/WNL.0000000000005614. Epub 2018 Apr 27.

PMID:
29703767
5.

Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis.

Mueller SH, Färber A, Prüss H, Melzer N, Golombeck KS, Kümpfel T, Thaler F, Elisak M, Lewerenz J, Kaufmann M, Sühs KW, Ringelstein M, Kellinghaus C, Bien CG, Kraft A, Zettl UK, Ehrlich S, Handreka R, Rostásy K, Then Bergh F, Faiss JH, Lieb W, Franke A, Kuhlenbäumer G, Wandinger KP, Leypoldt F; German Network for Research on Autoimmune Encephalitis (GENERATE).

Ann Neurol. 2018 Apr;83(4):863-869. doi: 10.1002/ana.25216.

PMID:
29572931
6.

Functional autoantibodies in patients with different forms of dementia.

Wallukat G, Prüss H, Müller J, Schimke I.

PLoS One. 2018 Mar 14;13(3):e0192778. doi: 10.1371/journal.pone.0192778. eCollection 2018.

7.

[Autoimmune encephalitis with psychotic symptoms : Diagnostics, warning signs and practical approach].

Steiner J, Prüß H, Köhler S, Hasan A, Falkai P.

Nervenarzt. 2018 May;89(5):530-538. doi: 10.1007/s00115-018-0499-z. Review. German.

PMID:
29523913
8.

Severe GABAA receptor encephalitis without seizures: A paediatric case successfully treated with early immunomodulation.

Nikolaus M, Knierim E, Meisel C, Kreye J, Prüss H, Schnabel D, Kallinich T.

Eur J Paediatr Neurol. 2018 May;22(3):558-562. doi: 10.1016/j.ejpn.2018.01.002. Epub 2018 Jan 9.

PMID:
29396172
9.

High prevalence and functional effects of serum antineuronal antibodies in patients with gastrointestinal disorders.

Lütt A, Michel K, Krüger D, Volz MS, Nassir M, Schulz E, Poralla L, Tangermann P, Bojarski C, Höltje M, Teegen B, Stöcker W, Schemann M, Siegmund B, Prüss H.

Neurogastroenterol Motil. 2018 Jun;30(6):e13292. doi: 10.1111/nmo.13292. Epub 2018 Jan 18.

PMID:
29345029
10.

Pursuing functional connectivity in NMDAR1 autoantibody carriers - Authors' reply.

Peer M, Prüss H, Ben-Dayan I, Paul F, Arzy S, Finke C.

Lancet Psychiatry. 2018 Jan;5(1):22. doi: 10.1016/S2215-0366(17)30488-1. No abstract available.

PMID:
29277209
11.

Morvan syndrome associated with CASPR2 and LGI1 antibodies in a child.

Nikolaus M, Jackowski-Dohrmann S, Prüss H, Schuelke M, Knierim E.

Neurology. 2018 Jan 23;90(4):183-185. doi: 10.1212/WNL.0000000000004861. Epub 2017 Dec 20. No abstract available.

PMID:
29263225
12.

A case of CLIPPERS challenging the new diagnostic criteria.

Rössling R, Pehl D, Lingnau M, Prüss H.

Brain. 2018 Feb 1;141(2):e12. doi: 10.1093/brain/awx335. No abstract available.

PMID:
29253092
13.

Superficial white matter damage in anti-NMDA receptor encephalitis.

Phillips OR, Joshi SH, Narr KL, Shattuck DW, Singh M, Di Paola M, Ploner CJ, Prüss H, Paul F, Finke C.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):518-525. doi: 10.1136/jnnp-2017-316822. Epub 2017 Nov 3.

PMID:
29101253
14.

Spinal cord injury-induced immunodeficiency is mediated by a sympathetic-neuroendocrine adrenal reflex.

Prüss H, Tedeschi A, Thiriot A, Lynch L, Loughhead SM, Stutte S, Mazo IB, Kopp MA, Brommer B, Blex C, Geurtz LC, Liebscher T, Niedeggen A, Dirnagl U, Bradke F, Volz MS, DeVivo MJ, Chen Y, von Andrian UH, Schwab JM.

Nat Neurosci. 2017 Nov;20(11):1549-1559. doi: 10.1038/nn.4643. Epub 2017 Sep 18.

PMID:
28920935
15.

Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study.

Peer M, Prüss H, Ben-Dayan I, Paul F, Arzy S, Finke C.

Lancet Psychiatry. 2017 Oct;4(10):768-774. doi: 10.1016/S2215-0366(17)30330-9. Epub 2017 Sep 4.

PMID:
28882707
16.

High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients.

Finke C, Bartels F, Lütt A, Prüss H, Harms L.

J Neurol. 2017 Sep;264(9):1968-1977. doi: 10.1007/s00415-017-8582-0. Epub 2017 Aug 7.

PMID:
28785798
17.

Frequencies of neuronal autoantibodies in healthy controls: Estimation of disease specificity.

Lang K, Prüss H.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 18;4(5):e386. doi: 10.1212/NXI.0000000000000386. eCollection 2017 Sep. Review.

18.

Synapsin-antibodies in psychiatric and neurological disorders: Prevalence and clinical findings.

Höltje M, Mertens R, Schou MB, Saether SG, Kochova E, Jarius S, Prüss H, Komorowski L, Probst C, Paul F, Bellmann-Strobl J, Gitler D, Benfenati F, Piepgras J, Ahnert-Hilger G, Ruprecht K.

Brain Behav Immun. 2017 Nov;66:125-134. doi: 10.1016/j.bbi.2017.07.011. Epub 2017 Jul 18.

PMID:
28733081
19.

Red Flags: Clinical Signs for Identifying Autoimmune Encephalitis in Psychiatric Patients.

Herken J, Prüss H.

Front Psychiatry. 2017 Feb 16;8:25. doi: 10.3389/fpsyt.2017.00025. eCollection 2017.

20.

Postviral autoimmune encephalitis: manifestations in children and adults.

Prüss H.

Curr Opin Neurol. 2017 Jun;30(3):327-333. doi: 10.1097/WCO.0000000000000445. Review.

PMID:
28234798
21.

Serum antibodies targeting neurons of the monoaminergic systems in Guillain-Barré syndrome.

Rink C, Görtzen A, Veh RW, Prüss H.

J Neurol Sci. 2017 Jan 15;372:318-323. doi: 10.1016/j.jns.2016.11.078. Epub 2016 Dec 3.

PMID:
28017237
22.

Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis.

Scheibe F, Prüss H, Mengel AM, Kohler S, Nümann A, Köhnlein M, Ruprecht K, Alexander T, Hiepe F, Meisel A.

Neurology. 2017 Jan 24;88(4):366-370. doi: 10.1212/WNL.0000000000003536. Epub 2016 Dec 21.

PMID:
28003505
23.

Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.

Finke C, Prüss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, Münte T, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T.

JAMA Neurol. 2017 Jan 1;74(1):50-59. doi: 10.1001/jamaneurol.2016.4226.

PMID:
27893017
24.

Reply: In vitro effects of a human monoclonal antibody against the N-methyl-d-aspartate receptor.

Kreye J, Wenke NK, Garner CC, Wardemann H, Prüss H.

Brain. 2017 Feb;140(2):e10. doi: 10.1093/brain/aww290. Epub 2016 Nov 17. No abstract available.

PMID:
27864269
25.

Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density.

Mikolajczak J, Zimmermann H, Kheirkhah A, Kadas EM, Oberwahrenbrock T, Muller R, Ren A, Kuchling J, Dietze H, Prüss H, Paul F, Hamrah P, Brandt AU.

Mult Scler. 2017 Dec;23(14):1847-1853. doi: 10.1177/1352458516677590. Epub 2016 Nov 3.

PMID:
27811337
26.

Impaired motor inhibition in adults who stutter - evidence from speech-free stop-signal reaction time tasks.

Markett S, Bleek B, Reuter M, Prüss H, Richardt K, Müller T, Yaruss JS, Montag C.

Neuropsychologia. 2016 Oct;91:444-450. doi: 10.1016/j.neuropsychologia.2016.09.008. Epub 2016 Sep 13.

PMID:
27619005
27.

Initial serum thyroid peroxidase antibodies and long-term outcomes in SREAT.

Litmeier S, Prüss H, Witsch E, Witsch J.

Acta Neurol Scand. 2016 Dec;134(6):452-457. doi: 10.1111/ane.12556. Epub 2016 Jan 12.

PMID:
26757046
28.

Natural Killer (NK) Cell Functionality after human Spinal Cord Injury (SCI): protocol of a prospective, longitudinal study.

Laginha I, Kopp MA, Druschel C, Schaser KD, Brommer B, Hellmann RC, Watzlawick R, Ossami-Saidi RR, Prüss H, Failli V, Meisel C, Liebscher T, Prilipp E, Niedeggen A, Ekkernkamp A, Grittner U, Piper SK, Dirnagl U, Killig M, Romagnani C, Schwab JM.

BMC Neurol. 2016 Sep 13;16:170. doi: 10.1186/s12883-016-0681-5.

29.

Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study.

Heine J, Ly LT, Lieker I, Slowinski T, Finke C, Prüss H, Harms L.

J Neurol. 2016 Dec;263(12):2395-2402. Epub 2016 Sep 7.

PMID:
27604620
30.

Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis.

Kreye J, Wenke NK, Chayka M, Leubner J, Murugan R, Maier N, Jurek B, Ly LT, Brandl D, Rost BR, Stumpf A, Schulz P, Radbruch H, Hauser AE, Pache F, Meisel A, Harms L, Paul F, Dirnagl U, Garner C, Schmitz D, Wardemann H, Prüss H.

Brain. 2016 Oct;139(Pt 10):2641-2652. Epub 2016 Aug 20.

PMID:
27543972
31.

All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class.

Castillo-Gómez E, Oliveira B, Tapken D, Bertrand S, Klein-Schmidt C, Pan H, Zafeiriou P, Steiner J, Jurek B, Trippe R, Prüss H, Zimmermann WH, Bertrand D, Ehrenreich H, Hollmann M.

Mol Psychiatry. 2017 Dec;22(12):1776-1784. doi: 10.1038/mp.2016.125. Epub 2016 Aug 9.

PMID:
27502473
32.

Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies.

Prüss H, Lennox BR.

J Neurol Neurosurg Psychiatry. 2016 Nov;87(11):1242-1247. doi: 10.1136/jnnp-2015-313000. Epub 2016 Jul 19. Review.

PMID:
27435086
33.

Delayed diagnosis of extraovarian teratoma in relapsing anti-NMDA receptor encephalitis.

Kümpfel T, Gerdes LA, Heck C, Prüss H.

Neurol Neuroimmunol Neuroinflamm. 2016 Jun 16;3(4):e250. doi: 10.1212/NXI.0000000000000250. eCollection 2016 Aug. No abstract available.

34.

[Pathophysiology and Prognostic Factors of Autoimmune Encephalitis].

Prüß H.

Fortschr Neurol Psychiatr. 2016 May;84(5):264-70. doi: 10.1055/s-0041-109127. Epub 2016 Jun 14. Review. German.

PMID:
27299785
35.

Devastating humoral CIDP variant remitted by autologous stem cell transplantation.

Scheibe F, Alexander T, Prüss H, Wengert O, Harms L, Angstwurm K, Hiepe F, Arnold R, Meisel A.

Eur J Neurol. 2016 Mar;23(3):e12-4. doi: 10.1111/ene.12896. No abstract available.

PMID:
26918747
36.

A clinical approach to diagnosis of autoimmune encephalitis.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J.

Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9. Epub 2016 Feb 20. Review.

37.

Altered paired associative stimulation-induced plasticity in NMDAR encephalitis.

Volz MS, Finke C, Harms L, Jurek B, Paul F, Flöel A, Prüss H.

Ann Clin Transl Neurol. 2016 Jan 16;3(2):101-13. doi: 10.1002/acn3.277. eCollection 2016 Feb.

38.

Visual dysfunction, but not retinal thinning, following anti-NMDA receptor encephalitis.

Brandt AU, Oberwahrenbrock T, Mikolajczak J, Zimmermann H, Prüss H, Paul F, Finke C.

Neurol Neuroimmunol Neuroinflamm. 2016 Feb 2;3(2):e198. doi: 10.1212/NXI.0000000000000198. eCollection 2016 Apr.

39.

Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis.

Berger B, Hottenrott T, Leubner J, Dersch R, Rauer S, Stich O, Prüss H.

BMC Neurol. 2015 Dec 11;15:255. doi: 10.1186/s12883-015-0515-x.

40.

Spinal cord injury-induced immune deficiency syndrome enhances infection susceptibility dependent on lesion level.

Brommer B, Engel O, Kopp MA, Watzlawick R, Müller S, Prüss H, Chen Y, DeVivo MJ, Finkenstaedt FW, Dirnagl U, Liebscher T, Meisel A, Schwab JM.

Brain. 2016 Mar;139(Pt 3):692-707. doi: 10.1093/brain/awv375. Epub 2016 Jan 10.

41.

Clinical Reasoning: A 57-year-old woman who developed acute amnesia following fever and upper respiratory symptoms.

Finke C, Prüss H.

Neurology. 2015 Nov 17;85(20):1822. doi: 10.1212/WNL.0000000000002162. No abstract available.

PMID:
26574538
42.

GRIN1 polymorphisms do not affect susceptibility or phenotype in NMDA receptor encephalitis.

Day GS, Prüss H, Benseler SM, Paton TA, Paterson AD, Andrade DM.

Neurol Neuroimmunol Neuroinflamm. 2015 Sep 24;2(5):e153. doi: 10.1212/NXI.0000000000000153. eCollection 2015 Oct.

43.

Anti-NMDA Receptor Encephalitis in the Polar Bear (Ursus maritimus) Knut.

Prüss H, Leubner J, Wenke NK, Czirják GÁ, Szentiks CA, Greenwood AD.

Sci Rep. 2015 Aug 27;5:12805. doi: 10.1038/srep12805.

44.

Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis.

Urbach H, Rauer S, Mader I, Paus S, Wagner J, Malter MP, Prüss H, Lewerenz J, Kassubek J, Hegen H, Auer M, Deisenhammer F, Ufer F, Bien CG, Baumgartner A.

Neuroradiology. 2015 Dec;57(12):1203-9. doi: 10.1007/s00234-015-1581-x. Epub 2015 Aug 21.

PMID:
26293130
45.

Autologous Serum Tears for Treatment of Photoallodynia in Patients with Corneal Neuropathy: Efficacy and Evaluation with In Vivo Confocal Microscopy.

Aggarwal S, Kheirkhah A, Cavalcanti BM, Cruzat A, Colon C, Brown E, Borsook D, Prüss H, Hamrah P.

Ocul Surf. 2015 Jul;13(3):250-62. doi: 10.1016/j.jtos.2015.01.005. Epub 2015 Feb 20.

46.

Imaging of autoimmune encephalitis--Relevance for clinical practice and hippocampal function.

Heine J, Prüss H, Bartsch T, Ploner CJ, Paul F, Finke C.

Neuroscience. 2015 Nov 19;309:68-83. doi: 10.1016/j.neuroscience.2015.05.037. Epub 2015 May 23. Review.

PMID:
26012492
47.

Structural Hippocampal Damage Following Anti-N-Methyl-D-Aspartate Receptor Encephalitis.

Finke C, Kopp UA, Pajkert A, Behrens JR, Leypoldt F, Wuerfel JT, Ploner CJ, Prüss H, Paul F.

Biol Psychiatry. 2016 May 1;79(9):727-34. doi: 10.1016/j.biopsych.2015.02.024. Epub 2015 Feb 26.

PMID:
25866294
48.

"Hirnsymptome bei Carcinomatose" - Hermann Oppenheim and an Early Description of a Paraneoplastic Neurological Syndrome.

Schulz P, Prüss H.

J Hist Neurosci. 2015;24(4):371-7. doi: 10.1080/0964704X.2015.1021120. Epub 2015 Mar 24.

49.

GAD Antibody-Associated Late-Onset Cerebellar Ataxia in Two Female Siblings.

Kuchling J, Shababi-Klein J, Nümann A, Gerischer LM, Harms L, Prüss H.

Case Rep Neurol. 2014 Nov 26;6(3):264-70. doi: 10.1159/000369784. eCollection 2014 Sep.

50.

High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types.

Doss S, Wandinger KP, Hyman BT, Panzer JA, Synofzik M, Dickerson B, Mollenhauer B, Scherzer CR, Ivinson AJ, Finke C, Schöls L, Müller Vom Hagen J, Trenkwalder C, Jahn H, Höltje M, Biswal BB, Harms L, Ruprecht K, Buchert R, Höglinger GU, Oertel WH, Unger MM, Körtvélyessy P, Bittner D, Priller J, Spruth EJ, Paul F, Meisel A, Lynch DR, Dirnagl U, Endres M, Teegen B, Probst C, Komorowski L, Stöcker W, Dalmau J, Prüss H.

Ann Clin Transl Neurol. 2014 Oct;1(10):822-32. doi: 10.1002/acn3.120. Epub 2014 Oct 18.

Supplemental Content

Support Center